This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

This study has suspended participant recruitment.
Sponsor:
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )
ClinicalTrials.gov Identifier:
NCT00804154
First received: December 5, 2008
Last updated: June 30, 2017
Last verified: May 9, 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 30, 2020
  Estimated Primary Completion Date: June 30, 2020 (Final data collection date for primary outcome measure)